GLYCOPHOS (Fresenius Kabi Australia Pty Ltd)
Product name
GLYCOPHOS
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
199 working days (255)
Active ingredients
sodium glycerophosphate hydrate
Registration type
NCE/NBE
Indication
GLYCOPHOS (concentrated solution for injection) is indicated in adult and paediatric patients as a supplement to parenteral nutrition to meet the daily requirements of phosphate.